Pricing Log in Create free account

Biophytis SA Sponsored ADR (BPTSY) vs Kairos Pharma, Ltd. (KAPA)

Biophytis SA Sponsored ADR and Kairos Pharma, Ltd. are both Biotechnology companies. Biophytis SA Sponsored ADR and Kairos Pharma, Ltd. are of similar size ($2.4M and $2.3M). Across the 9 metrics below, Biophytis SA Sponsored ADR leads on 6 and Kairos Pharma, Ltd. on 3.

Valuation

Metric BPTSY KAPA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 0.44 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.14 0.64
EV/Sales n/m n/m 9.21
Earnings yield (126.92%) (326.58%) (33.15%)
Free cash flow yield (2,235.65%) (216.16%) (25.50%)

Profitability

Metric BPTSY KAPA Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (113.96%) (56.36%)
Return on assets 0.00% (104.32%) (48.04%)
Return on invested capital 0.00% (322.91%) 0.00%

Growth

Metric BPTSY KAPA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (59.60%) (30.44%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BPTSY KAPA Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 0.35 11.98 4.72
Net debt to EBITDA (1.24) 1.65 0.96

Dividend

Metric BPTSY KAPA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BPTSY KAPA Biotechnology median
Market cap 2.36m 2.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack